Effectiveness of Dry Eye Treatment With Diquafosol Sodium 3% After Phaco Surgery

Le Xuan Cung

Status: Completed

Conditions: Dry Eye Disease

Treatments: Drug: Diquafosol Sodium 3%

Study type: Observational

Funder types: Other

Identifiers

NCT07122635

764/QD-BVMTW No. 17

Details and patient eligibility

About

The goal of this observational study is to evaluate the effectiveness of diquafosol sodium 3% in patients undergoing phacoemulsification surgery and having dry eye 1 week after the surgery. The main question it aims to answer is whether using diquafosol will help improve symptoms and signs of dry eye in patients after phaco surgery.

Enrollment: 60 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients undergoing phacoemulsification surgery with IOL implantation
• Diagnosis with grade 1, grade 2 or grade 3 dry eye one week after the surgery according to DEWS 2007 classification and Sullivan's severity grading scheme

Exclusion criteria

• Patients with grade 3 or 4 dry eye before phaco surgery
• Phaco surgery with complications during or after surgery
• Patients with other eye surgeries within 6 months before phaco surgery
• Patients who are using other eye drops before phaco surgery, except artificial tears
• Patients with acute eye infections
• Patients who do not return for follow-up appointments
• Patients who do not comply with treatment
• Patients having allergy with diquafosol 3%
• Patients having side effects with diquafosol 3% and do not want to continue using the drug

Trial design

60 participants in 1 patient group

Patients undergoing phacoemulsification surgery and having dry eye 1 week after the surgery

Treatment:

Drug: Diquafosol Sodium 3%